Substance P and NK-1R expression in oral precancerous epithelium


Autoria(s): GONZALEZ-MOLES, M. A.; BRENER, S.; RUIZ-AVILA, I.; GIL-MONTOYA, J. A.; TOSTES, D.; BRAVO, M.; ESTEBAN, F.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2009

Resumo

The objectives of this study were to investigate the presence and distribution of substance P and neurokinin 1 receptor in oral premalignant epithelium and their relation with the presence of dysplasia, and to analyze whether the expression of substance P can be considered an early oncogenic event in oral carcinogenesis. Substance P and neurokinin I receptor expression was immunohistochemically studied in 83 oral carcinomas and adjacent nontumor epithelia. The presence and degree of epithelial dysplasia was assessed according to WHO criteria. The nuclear, cytoplasmic, and membrane expression of substance P and the cytoplasmic and membrane expression of neurokinin 1 receptor were assessed in tumor and adjacent non-tumor epithelium. Nuclear and cytoplasmic expression of substance P in non-tumor epithelium was significantly associated with the presence of epithelial dysplasia (p<0.001) and carcinoma in. situ (p=0.021). Nuclear, cytoplasmic, and membrane expressions of substance P in non-tumor epithelium were significantly (p<0.001) associated with its expression in the corresponding tumor. These findings suggest that substance P plays a role in early oral carcinogenesis by promoting the proliferation and growth of premalignant fields.

Identificador

ONCOLOGY REPORTS, v.22, n.6, p.1325-1331, 2009

1021-335X

http://producao.usp.br/handle/BDPI/25967

10.3892/or_00000571

http://dx.doi.org/10.3892/or_00000571

Idioma(s)

eng

Publicador

SPANDIDOS PUBL LTD

Relação

Oncology Reports

Direitos

restrictedAccess

Copyright SPANDIDOS PUBL LTD

Palavras-Chave #substance P #NK-1 receptor #precancerous epithelium #oral cancer #GENETIC PROGRESSION MODEL #GLIOMA-CELL LINES #ANTITUMORAL ACTION #CLINICAL-IMPLICATIONS #MITOGENIC ACTION #NK1 RECEPTOR #CANCER #L-733,060 #NEUROBLASTOMA #ACTIVATION #Oncology
Tipo

article

original article

publishedVersion